Skip to main content
Equibles

Akshay K. Vaishnaw, M.D., Ph.D.

CIO

Alnylam Pharmaceuticals, Inc. (ALNY)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Akshay K. Vaishnaw, M.D., Ph.D.

Akshay K. Vaishnaw, M.D., Ph.D. is recorded as CIO at Alnylam Pharmaceuticals, Inc. (ALNY). Alnylam Pharmaceuticals, Inc. reported in an 8-K filed August 3, 2023 that Akshay K. Vaishnaw, M.D., Ph.D. was appointed Chief Innovation Officer, effective October 2, 2023. Alnylam Pharmaceuticals, Inc. reported in an 8-K filed August 3, 2023 that Akshay K. Vaishnaw, M.D., Ph.D. resigned as President, effective October 2, 2023.

“Dr. Vaishnaw will leave his current position as President of the Company and transition to a part-time role as Chief Innovation Officer, effective October 2, 2023 (the "Transition Date").”
Alnylam Pharmaceuticals, Inc. Form 8-K, filed August 3, 2023 · Read the filing
“On July 31, 2023, the Company and Akshay K. Vaishnaw, M.D., Ph.D. entered into a letter agreement (the "Letter Agreement"), whereby Dr. Vaishnaw will leave his current position as President of the Company and transition to a part-time role as Chief Innovation Officer, effective October 2, 2023 (the "Transition Date").”
Alnylam Pharmaceuticals, Inc. Form 8-K, filed August 3, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Alnylam Pharmaceuticals, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.